Dr. Jens Thiel provided a detailed overview of specific treatments for patients with immunoglobulin A (IgA) vasculitis and IgA nephropathy, highlighting treatments in early clinical trials.
Tofacitinib Increases Risk of Venous Thromboembolism
Background & Objectives The ORAL Surveillance trial (NCT02092467), a postauthorization safety study of tofacitinib in patients with rheumatoid arthritis (RA) aged 50 years or older with at least one additional cardiovascular risk factor, found a dose-dependent increase in venous thromboembolism (VTE) and pulmonary embolism (PE) events when patients were treated with tofacitinib vs. a tumor…
FDA Approves Sarilumab for pJIA
The FDA has granted sarilumab its first pediatric indication, approving the agent to treat active, polyarticular juvenile idiopathic arthritis (pJIA) in patients who weigh at least 63 kgs.
Summary of Notable Provisions in CY 2025 Medicare PFS Proposed Rule
The ACR will provide comments on several provisions related to Medicare physician payment and the Quality Payment Program.
RheumPAC Donor Perks Available at ACR Convergence 2024
Registration for ACR Convergence 2024 is now open, and RheumPAC is thrilled to announce exciting perks for 2024 supporters during the conference. Contributors will have access to the RheumPAC Lounge, where they can enjoy refreshments and chat with RheumPAC Committee members and ACR staff. ACR staff are also finalizing plans for this year’s RheumPAC donor…
The ACR’s Top Legislative Priority: Reforming Medicare Reimbursement
The ACR is encouraged that lawmakers are discussing Medicare physician payment reform and continues to work to educate lawmakers about the importance of both short- and long-term policy solutions. Support grassroots efforts by messaging your lawmakers today.
‘Don’t Block Patient Access to Records,’ says HHS to Healthcare Providers
The Department of Health & Human Services has released a final rule that would penalize healthcare providers who interfere with a patient’s access to, exchange or use of their electronic health information.
APEX 2024 Winners Announced: The Rheumatologist Receives 2 Awards of Excellence
FDA Updates Safety & Efficacy Information for Voclosporin
The FDA’s latest label change for voclosporin adds data demonstrating its safety and efficacy, as well as a sustained renal response, in patients with lupus nephritis through three years of treatment.
Rheum for Everyone, Episode 10: Demystifying AI
Hosted by Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS, physician editor, The Rheumatologist Amidst mounting excitement over emerging artificial intelligence tools, Dr. Kumar cautions against the expectation that technology will offer a quick fix to complex, systemic healthcare problems. Go to current issue.
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 815
- Next Page »